These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31563411)

  • 1. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
    Niyazi M; Niemierko A; Paganetti H; Söhn M; Schapira E; Goldberg S; Adams J; Kim V; Oh KS; Hwang WL; Lu HM; Belka C; Busse PM; Loeffler JS; Shih HA
    Radiother Oncol; 2020 Jan; 142():154-161. PubMed ID: 31563411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
    McDonald MW; Liu Y; Moore MG; Johnstone PA
    Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma.
    Zhang YY; Huo WL; Goldberg SI; Slater JM; Adams JA; Deng XW; Sun Y; Ma J; Fullerton BC; Paganetti H; Loeffler JS; Lu HM; Chan AW
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):984-992. PubMed ID: 33600889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.
    Engeseth GM; Hysing LB; Yepes P; Pettersen HES; Mohan R; Fuller CD; Stokkevåg CH; Wu R; Zhang X; Frank SJ; Gunn GB
    Acta Oncol; 2022 Feb; 61(2):215-222. PubMed ID: 34534047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
    Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
    Pedersen J; Flampouri S; Bryant C; Liang X; Mendenhall N; Li Z; Liu M; Muren LP
    Radiother Oncol; 2020 Jan; 142():253-260. PubMed ID: 31630864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
    Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
    Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions.
    Wang D; Dirksen B; Hyer DE; Buatti JM; Sheybani A; Dinges E; Felderman N; TenNapel M; Bayouth JE; Flynn RT
    Med Phys; 2014 Dec; 41(12):121705. PubMed ID: 25471952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
    Dennis ER; Bussiere MR; Niemierko A; Lu MW; Fullerton BC; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2013 Feb; 12(1):1-9. PubMed ID: 22775339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Schröder C; Köthe A; De Angelis C; Basler L; Fattori G; Safai S; Leiser D; Lomax AJ; Weber DC
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):448-455. PubMed ID: 35124132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.
    Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
    Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
    BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis.
    Chamseddine I; Shah K; Lee H; Ehret F; Schuemann J; Bertolet A; Shih HA; Paganetti H
    Clin Cancer Res; 2024 Oct; 30(19):4424-4433. PubMed ID: 39106090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.